Company
ChinaGuangdong Lewwin Pharmaceutical Research Institute, Guangzhou, China – FDA Inspections
Inspection records and compliance data for Guangdong Lewwin Pharmaceutical Research Institute in Guangzhou. 1 FDA inspection on record, 1 Form 483, last inspected November 14, 2025.
Company Profile
This profile covers Guangdong Lewwin Pharmaceutical Research Institute based in Guangzhou, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected November 14, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 14, 2025 | Not classified | Human Drugs | 1293328 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Hangzhou Longyang Biotechnology Co., Ltd.
Yuen-Sheung Ngan, Hextan, M.B.B.S.,Hong Kong,M.R.C.O.G
Shandong Luwei Pharmaceutical Co.,Ltd.
Liaoyuan Silver Eagle Pharmaceutical Co., Ltd.
EnzymeKing Biotechnology Co, .Ltd
China National Analytical Center
Jianying Xi
Langfang Gaobo Jingband Pharmaceutical Co., Ltd.
Qingdao University of Science and Technology
Hangzhou SunKing Nonwovens Co., Ltd.
Company Information
Name
Guangdong Lewwin Pharmaceutical Research Institute
FEI Number
3032233074
Address
Chuangye Road, High-Tech Industrial Park No. 65, Conghua; Taipingzhen Conghua, Guangzhou, China
Country
China
ID: df7c1a02-38c3-4120-810c-2fdd5293b83f